GNC has filed for Chapter 11 bankruptcy protection with plans to close at least 800 to 1,200 stores as it looks to cut its debt and restructure amid the COVID-19 crisis.
Bausch + Lomb will be responsible for sales, marketing, and other commercialization efforts for biosimilar Lucentis, following regulatory approval in the United States and Canada.
With plans to sell 65.8 million shares of its common stock on the New York Stock Exchange under the ticker symbol ABI, Albertsons could bring in between $1.2 billion and $1.3 billion with its initial public offering.